CA2202497A1 - Particles including degradable material and anti-microbial agent - Google Patents
Particles including degradable material and anti-microbial agentInfo
- Publication number
- CA2202497A1 CA2202497A1 CA002202497A CA2202497A CA2202497A1 CA 2202497 A1 CA2202497 A1 CA 2202497A1 CA 002202497 A CA002202497 A CA 002202497A CA 2202497 A CA2202497 A CA 2202497A CA 2202497 A1 CA2202497 A1 CA 2202497A1
- Authority
- CA
- Canada
- Prior art keywords
- particle
- water
- microbial agent
- mouth
- stable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/85—Polyesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Abstract
A method for inhibiting bacteria in the mouth of a patient which includes placing a particle containing a degradable material and an anti-microbial agent in the mouth of the patient. The exterior of the particle is water-stable. The particles may be coated on dental floss or the bristles of a toothbrush, or incorporated into an oral rinse. Once placed in the mouth, the degradable material degrades to cause release of the anti-microbial agent, resulting in the inhibition of bacteria in the mouth.
Description
W096/11666 PCT~S95/13337 PARTICLES INCL~DING DEq~ RT~
MATERIA~ AND ANTI-MICROBIAL AGENT
The invention relates to systems for delivering anti-microbial agents to the mouth.
Many humans suffer from tooth decay and periodontal disease caused by bacteria in the mouth. As a result, decreasing the number of these bacteria is a problem which has been targeted by m~hers of the dental and health care fields. The most common way of minimizing the number of bacteria is to brush and floss the teeth regularly, and to visit a dental hygienist to have the teeth and gums cleaned thoroughly.
Another approach to control bacteria in the mouth is to rinse with a solution conta;n;ng an ef$ective anti-microbial agent, such as chlorhexidene digluconate.
One of the major side effects of rinsing with a chlorhexidene-based solution is a yellow-brown stain which may develop on the teeth, tongue, and fillings. Although this stain can usually be professionally removed, it is not cosmetically pleasing. In addition to the st~; n; ng, taste disturbances, such as the perception of sweets and salt, m~y de~elop due to the presence of chlorhexidene. In certain patients, scaling and soreness of the oral W096/11666 PCT~S95/13337 mucosa may occur. These side effects have been attributed to the high concentration of chlorhexidene (or salt thereof) used in the rinse; it is, therefore, desirable to reduce or control the dosage of chlorhexidene 80 that anti-microbial effects can be achieved without the onset of undesirable side effects.
In general, the invention features a method for inhibiting bacteria in the mouth of a patient. The method includes placing a particle conta; n; ng a degradable material and an anti-microbial agent into the mouth of a patient. The sali~a in the mouth causes the degradable material in the particle to degrade, resulting in the release of the anti-microbial agent in a controlled manner over time. The exterior of the particle is water-stable allowing the particles to be incorporated into, for example, agueous rinses or pastes without the water in the rinse or paste causing the degradable material to degrade prematurely, prior to use.
In one embodiment, the particle is pro~ided with a coating composed of a water-stable material that does not degrade when exposed to one or more enzymes in the mouth.
These materials include hydrophobic materials like poly(methyl methacrylate), polystyrene, beeswax, carnauba wax, petroleum wax, or similar materials. The coating is disrupted by mechanical stresses (e.g., brl~R~;ng, flossing, and chewing); this disruption exposes the underlying degradable material to sali~a. As a result, the degradable material degrades, causing the anti-microbial agent to be released.
In another embodiment, the particle is pro~ided with a coating of a water-stable material that degrades when exposed to one or W096/11666 PCT~S9S/13337 more enzymes in the mouth. Examples of such materials include polyhydroxyal~anoic acid, glycolipids, glycerides, and phospholipids. As the water-stable material degrades by the action of enzymes in the mouth, the underlying degradable material is exposed to sali~a and also degrades, resulting in the release of the anti-microbial agent. The water-stable material may also be disrupted by mechanical stresses.
In another ~hodiment, the particle includes a water-stable material, dispersed throughout the particle, that degrades when exposed to enzymes in the mouth. In this embodiment, the water-stable material (l) functions as the degradable material, and (2) functions to pro~ide the particle with a water-stable exterior. Optionally, the particle may include one or more other degradable materials underneath the water-stable exterior, and also may include one or more other water-stable materials that help pro~ide the water-stable exterior. A preferred material that can be used for this embodiment is glycerol distearate.
Preferred anti-microbial agents include phenolic compound~ (monomeric or polymeric, synthetic or natural); nature derived anti-microbials such as sanguinarine:
cetylpyridinium salts; benzal~ um salts;
benzethonium salts; domiphen salts;
bisbiguanides, such as chlorhexidene;
bisbiguanide salts; phosphonium salts; ammonium salts; peroxides and other oxidants; zinc salts;
and antibiotics such as penicillin, vancomycin, kanamycin, erythromycin, niddamycin, spiramycin, tetracycline, minocycline, and metronidazole.
Particularly preferred anti-microbial agents include chlorhexidene or an acceptable salt of W096/11666 ~CT~S95/13337 chlorhexidene.
Preferred degradable materials include polyglycolic acid, polylactic acid, and copolymers of glycolic acid and lactic acid, and esters of glycerol.
In some preferred embodiments, the degradable material encapsulates the anti-microbial agent. In other preferred embodiments, the particle is a microsphere, and the diameter of the microsphere is preferably between 0.05 ~m and lO0 ~m, more preferably between O.l ~m and 30 ~m.
In another aspe~t, the invention features a toothbrush including a handle and, ext~n~ng from a portion of the handle, bristles coated with the particles of the invention, or hollow bristles that are partially or totally filled with the particles. In another aspect, the invention features dental floss including an elongated, flexible cord (preferably made of nylon or other durable polymer) coated with the particles of the invention. In still another aspect, the invention features a toothpaste or an oral rinse cont~; n i ng the particles of the invention. The toothpaste generally includes other conventional components such as an abrasive (e.g., silica or alumina, having a particle size of between 5 ~m and 50 ~m), a thic~ner (e.g., colloidal silica having a particle size of between O.l ~m and l ~m), and a flavor.
"Encapsulate", as used herein, means that the anti-microbial agent is dispersed throughout or surrounded by the degradable material.
"Degradab1e material", as used herein, means a material which degrades within three W096111666 PCT~S95/13337 months when placed in the mouth of a typical patient. The materials degrade as a result of exposure to one or more enzymes that commonly are found in the mouth. These enzymes include lipases, proteases, and glucosidases. Specific enzymes include parotid amylase, hyaluronidase, beta-glucuron;~e, r~on~roitin sulfatase, amino acid ~r~rhoYylases, catalase, peroxidase (such as lacto peroxidase), collagenase, and lysozyme.
"Water-stable exterior", as used herein, means that the exterior surface of the particle iB composed of a material that does not chemically degrade or swell when exposed to water. As a result of the water-stable exterior, substantially no (i.e., less than 5%
by weight) anti-microbial agent le~r~e~ from the particle when the particle is placed in distilled water (at a concentration of 10% of the dispersion by weight) at room temperature for a month.
"Microsphere", as used herein, means that the particle is substantially spherical in shape.
The particles of the in~ention can be used to deliver an anti-microbial agent at a predetermined rate for a defined time period.
The degradable material essentially allows for continuous inhibition of bacteria in the mouth during the selected time period without necessitating a large initial dosage of the anti-microbial agent. The dosage optionally may be provided in a site-specific manner. The water-stable exterior allows the particles to be stored for a substantial period of time, for example in a mouthwash or a toothpaste.
When chlorhexidene is selected as the anti-microbial agent, the controlled delivery W096/11666 PCT~S95tl3337 process of the invention results in a reduction of undesirable side effects, such as ~t~n;ng of the teeth and tongue. Sig~ificantly, when the particles are composed primarily of a degradable material and an anti-microbial agent, substantially nothing remains of the particles in the mouth or body once the degradable material degrades and all of the anti-microbial agent is relea~ed.
The preferred particles include a degradable material, an anti-microbial agent, and a thin (e.g., less than 10 ~m) non-porous coating that makes the exterior surface of the particle water-stable.
Preferred degradable materials include polymers such as polycaprolactone, poly~^calactone, poly(sebacic anhydride), sebacic acid-co-1,3-bis(caLbo~y~h~nQ~yypropane)~
sebacic acid-co-1,6-bis(carboxy~henoYyh~Yane), ~e~ecanoic-co-1,3-bis(carboxyrh~noYypropane), ~ecanoic-co-1~6-bis(carbO
albumin and derivatives, gelatin and derivatives, starch and derivatives, gum arabic, cellulose and derivatives, polysorbate and derivatives, agarose, lectins, galactose, functionalized nylons (e.g. benzylated), protein~ (synthetic and natural), polyorthoesters, polyorthoformate, polyureas, polyurethane~, poly(amide-enamine) 8, polyvinylalcohol, polyenolketone (PER), polyHema, functionalized polyHema, ethylene-vinylacetate copolymers, functionalized polymers and copolymers of lactic and glycolic acid, lactic acid homopolymer, glycolic acid copolymer, copolymers of lactic acid and glycolic acid, polyhyd o~yLutyrate~
poly(esterimides), functionalized silicones, W096/11666 PCT~S95/13337 poly(anhydrides), poly(malic acid), and polyhydroxyalkanoic acid from synthetic or natural sources (bacterial, fungi and the like).
Other preferred degradable materials include monomeric species and mixed monomeric/polymeric species such as liposomes, glycolipids, fatty acids, glycerides, carnauba wax, and phospholipids.
The preferred degradable materials can be included in organic/inorganic composites.
The composites can include any of the polymers listed above mixed or covalently bound with minerals such as silica, alumina, kaolin, morierite, cordierite, zirconia minerals and the like; any of the monomeric and monomer/polymer species listed abo~e mixed or co~alently bound with minerals such as silica, alumina, kaolin, morierite, cordierite, zirconia minerals and the like; proteins bound to silica, titania, and the like; silicon-contain;ng polymers; and polyhyd~o~y-lkanoic acid:salt complexes. The inorganic component(s) of the composite can, for instance, assist in controlling the dosage of anti-microbial agent released in a given period of time, or act as an abrasive if used, e.g., in a toothpaste.
The more preferred degradable materials are polymers such as polyglycolic acid, polylactic acid, and copolymers of glycolic acid and lactic acid, and esters of glycerol. These polymers are well-known and commercially available. For example, polyglycolic acid is available from the American Cyana~;d Company (Dexon~) and Polysciences, Inc.; polylactic acid is available from Polysciences, Inc.; and copolymers of glycolic acid and lactic acid are a~ailable from American W096/11666 PCT~S95/13337 Cyan~m;d Company (Vicryl~), Ethicon, Inc.
(Polyglactin 910) and Polysciences.
Alternatively, the polymers can be synthesized according to known procedures. For example, polyglycolic acid can be prepared employing the ring opening polymerization of the dimeric ester of glycolic acid; polylactic acid can be prepared e_ploying the ring opening polymeriza-tion of the dimeric ester of lactic acid; and copolymers of glycolic acid and lactic acid can be prepared employing the ring opening polymerization of the correspon~;ng dimeric esters.
Other preferred degradable polymeric materials are commercially available and/or may be prepared by known procedures.
A particularly preferred anti-microbial agent is chlorhexidene, an anti-bacterial compound which contains two biguanide moieties, each attache~ in the para position to a separate chlorophenyl group, and joined by a h~Yan~ linkage (see, for example, Rose et al., J. Chem Soc., p. 4422 (1956) and U.S. Pat. No.
MATERIA~ AND ANTI-MICROBIAL AGENT
The invention relates to systems for delivering anti-microbial agents to the mouth.
Many humans suffer from tooth decay and periodontal disease caused by bacteria in the mouth. As a result, decreasing the number of these bacteria is a problem which has been targeted by m~hers of the dental and health care fields. The most common way of minimizing the number of bacteria is to brush and floss the teeth regularly, and to visit a dental hygienist to have the teeth and gums cleaned thoroughly.
Another approach to control bacteria in the mouth is to rinse with a solution conta;n;ng an ef$ective anti-microbial agent, such as chlorhexidene digluconate.
One of the major side effects of rinsing with a chlorhexidene-based solution is a yellow-brown stain which may develop on the teeth, tongue, and fillings. Although this stain can usually be professionally removed, it is not cosmetically pleasing. In addition to the st~; n; ng, taste disturbances, such as the perception of sweets and salt, m~y de~elop due to the presence of chlorhexidene. In certain patients, scaling and soreness of the oral W096/11666 PCT~S95/13337 mucosa may occur. These side effects have been attributed to the high concentration of chlorhexidene (or salt thereof) used in the rinse; it is, therefore, desirable to reduce or control the dosage of chlorhexidene 80 that anti-microbial effects can be achieved without the onset of undesirable side effects.
In general, the invention features a method for inhibiting bacteria in the mouth of a patient. The method includes placing a particle conta; n; ng a degradable material and an anti-microbial agent into the mouth of a patient. The sali~a in the mouth causes the degradable material in the particle to degrade, resulting in the release of the anti-microbial agent in a controlled manner over time. The exterior of the particle is water-stable allowing the particles to be incorporated into, for example, agueous rinses or pastes without the water in the rinse or paste causing the degradable material to degrade prematurely, prior to use.
In one embodiment, the particle is pro~ided with a coating composed of a water-stable material that does not degrade when exposed to one or more enzymes in the mouth.
These materials include hydrophobic materials like poly(methyl methacrylate), polystyrene, beeswax, carnauba wax, petroleum wax, or similar materials. The coating is disrupted by mechanical stresses (e.g., brl~R~;ng, flossing, and chewing); this disruption exposes the underlying degradable material to sali~a. As a result, the degradable material degrades, causing the anti-microbial agent to be released.
In another embodiment, the particle is pro~ided with a coating of a water-stable material that degrades when exposed to one or W096/11666 PCT~S9S/13337 more enzymes in the mouth. Examples of such materials include polyhydroxyal~anoic acid, glycolipids, glycerides, and phospholipids. As the water-stable material degrades by the action of enzymes in the mouth, the underlying degradable material is exposed to sali~a and also degrades, resulting in the release of the anti-microbial agent. The water-stable material may also be disrupted by mechanical stresses.
In another ~hodiment, the particle includes a water-stable material, dispersed throughout the particle, that degrades when exposed to enzymes in the mouth. In this embodiment, the water-stable material (l) functions as the degradable material, and (2) functions to pro~ide the particle with a water-stable exterior. Optionally, the particle may include one or more other degradable materials underneath the water-stable exterior, and also may include one or more other water-stable materials that help pro~ide the water-stable exterior. A preferred material that can be used for this embodiment is glycerol distearate.
Preferred anti-microbial agents include phenolic compound~ (monomeric or polymeric, synthetic or natural); nature derived anti-microbials such as sanguinarine:
cetylpyridinium salts; benzal~ um salts;
benzethonium salts; domiphen salts;
bisbiguanides, such as chlorhexidene;
bisbiguanide salts; phosphonium salts; ammonium salts; peroxides and other oxidants; zinc salts;
and antibiotics such as penicillin, vancomycin, kanamycin, erythromycin, niddamycin, spiramycin, tetracycline, minocycline, and metronidazole.
Particularly preferred anti-microbial agents include chlorhexidene or an acceptable salt of W096/11666 ~CT~S95/13337 chlorhexidene.
Preferred degradable materials include polyglycolic acid, polylactic acid, and copolymers of glycolic acid and lactic acid, and esters of glycerol.
In some preferred embodiments, the degradable material encapsulates the anti-microbial agent. In other preferred embodiments, the particle is a microsphere, and the diameter of the microsphere is preferably between 0.05 ~m and lO0 ~m, more preferably between O.l ~m and 30 ~m.
In another aspe~t, the invention features a toothbrush including a handle and, ext~n~ng from a portion of the handle, bristles coated with the particles of the invention, or hollow bristles that are partially or totally filled with the particles. In another aspect, the invention features dental floss including an elongated, flexible cord (preferably made of nylon or other durable polymer) coated with the particles of the invention. In still another aspect, the invention features a toothpaste or an oral rinse cont~; n i ng the particles of the invention. The toothpaste generally includes other conventional components such as an abrasive (e.g., silica or alumina, having a particle size of between 5 ~m and 50 ~m), a thic~ner (e.g., colloidal silica having a particle size of between O.l ~m and l ~m), and a flavor.
"Encapsulate", as used herein, means that the anti-microbial agent is dispersed throughout or surrounded by the degradable material.
"Degradab1e material", as used herein, means a material which degrades within three W096111666 PCT~S95/13337 months when placed in the mouth of a typical patient. The materials degrade as a result of exposure to one or more enzymes that commonly are found in the mouth. These enzymes include lipases, proteases, and glucosidases. Specific enzymes include parotid amylase, hyaluronidase, beta-glucuron;~e, r~on~roitin sulfatase, amino acid ~r~rhoYylases, catalase, peroxidase (such as lacto peroxidase), collagenase, and lysozyme.
"Water-stable exterior", as used herein, means that the exterior surface of the particle iB composed of a material that does not chemically degrade or swell when exposed to water. As a result of the water-stable exterior, substantially no (i.e., less than 5%
by weight) anti-microbial agent le~r~e~ from the particle when the particle is placed in distilled water (at a concentration of 10% of the dispersion by weight) at room temperature for a month.
"Microsphere", as used herein, means that the particle is substantially spherical in shape.
The particles of the in~ention can be used to deliver an anti-microbial agent at a predetermined rate for a defined time period.
The degradable material essentially allows for continuous inhibition of bacteria in the mouth during the selected time period without necessitating a large initial dosage of the anti-microbial agent. The dosage optionally may be provided in a site-specific manner. The water-stable exterior allows the particles to be stored for a substantial period of time, for example in a mouthwash or a toothpaste.
When chlorhexidene is selected as the anti-microbial agent, the controlled delivery W096/11666 PCT~S95tl3337 process of the invention results in a reduction of undesirable side effects, such as ~t~n;ng of the teeth and tongue. Sig~ificantly, when the particles are composed primarily of a degradable material and an anti-microbial agent, substantially nothing remains of the particles in the mouth or body once the degradable material degrades and all of the anti-microbial agent is relea~ed.
The preferred particles include a degradable material, an anti-microbial agent, and a thin (e.g., less than 10 ~m) non-porous coating that makes the exterior surface of the particle water-stable.
Preferred degradable materials include polymers such as polycaprolactone, poly~^calactone, poly(sebacic anhydride), sebacic acid-co-1,3-bis(caLbo~y~h~nQ~yypropane)~
sebacic acid-co-1,6-bis(carboxy~henoYyh~Yane), ~e~ecanoic-co-1,3-bis(carboxyrh~noYypropane), ~ecanoic-co-1~6-bis(carbO
albumin and derivatives, gelatin and derivatives, starch and derivatives, gum arabic, cellulose and derivatives, polysorbate and derivatives, agarose, lectins, galactose, functionalized nylons (e.g. benzylated), protein~ (synthetic and natural), polyorthoesters, polyorthoformate, polyureas, polyurethane~, poly(amide-enamine) 8, polyvinylalcohol, polyenolketone (PER), polyHema, functionalized polyHema, ethylene-vinylacetate copolymers, functionalized polymers and copolymers of lactic and glycolic acid, lactic acid homopolymer, glycolic acid copolymer, copolymers of lactic acid and glycolic acid, polyhyd o~yLutyrate~
poly(esterimides), functionalized silicones, W096/11666 PCT~S95/13337 poly(anhydrides), poly(malic acid), and polyhydroxyalkanoic acid from synthetic or natural sources (bacterial, fungi and the like).
Other preferred degradable materials include monomeric species and mixed monomeric/polymeric species such as liposomes, glycolipids, fatty acids, glycerides, carnauba wax, and phospholipids.
The preferred degradable materials can be included in organic/inorganic composites.
The composites can include any of the polymers listed above mixed or covalently bound with minerals such as silica, alumina, kaolin, morierite, cordierite, zirconia minerals and the like; any of the monomeric and monomer/polymer species listed abo~e mixed or co~alently bound with minerals such as silica, alumina, kaolin, morierite, cordierite, zirconia minerals and the like; proteins bound to silica, titania, and the like; silicon-contain;ng polymers; and polyhyd~o~y-lkanoic acid:salt complexes. The inorganic component(s) of the composite can, for instance, assist in controlling the dosage of anti-microbial agent released in a given period of time, or act as an abrasive if used, e.g., in a toothpaste.
The more preferred degradable materials are polymers such as polyglycolic acid, polylactic acid, and copolymers of glycolic acid and lactic acid, and esters of glycerol. These polymers are well-known and commercially available. For example, polyglycolic acid is available from the American Cyana~;d Company (Dexon~) and Polysciences, Inc.; polylactic acid is available from Polysciences, Inc.; and copolymers of glycolic acid and lactic acid are a~ailable from American W096/11666 PCT~S95/13337 Cyan~m;d Company (Vicryl~), Ethicon, Inc.
(Polyglactin 910) and Polysciences.
Alternatively, the polymers can be synthesized according to known procedures. For example, polyglycolic acid can be prepared employing the ring opening polymerization of the dimeric ester of glycolic acid; polylactic acid can be prepared e_ploying the ring opening polymeriza-tion of the dimeric ester of lactic acid; and copolymers of glycolic acid and lactic acid can be prepared employing the ring opening polymerization of the correspon~;ng dimeric esters.
Other preferred degradable polymeric materials are commercially available and/or may be prepared by known procedures.
A particularly preferred anti-microbial agent is chlorhexidene, an anti-bacterial compound which contains two biguanide moieties, each attache~ in the para position to a separate chlorophenyl group, and joined by a h~Yan~ linkage (see, for example, Rose et al., J. Chem Soc., p. 4422 (1956) and U.S. Pat. No.
2,684,924). Pharmaceutically acceptable salts of chlorhexidene, such as chlorhexidene gluconate, chlorhexidene diacetate, chlorhexidene dihydrochloride, chlorhexidene dihydrofluoride, and chlorhexidene dihydrobromide may also be used in the present invention. Chlorhexidene and its associated salts are commercially available; the gluconate salt may be purchased, for example, as a 20.5 percent w/w aqueous solution from Pliva Pharmaceutical of Zagreb, Yugoslavia, and from ICI ~td. of England. Chlorhexidene gluconate as a freeze-dried solid is available from Pliva Pharmaceutical.
WO96/11666 PCT~S95/13337 Other preferred anti-micro~ial agents were described above and generally, like chlorhexidene digluconate, are commercially a~ailable.
The particles preferably include between 1% and 75%, and more preferably betwoen 1% and 25%, of the anti-microbial agent by weight. Too much anti-microbial agent may adversely affect the mechanical strength of the particle, while too little anti-microbial agent may result in an insufficient dosage of the anti-microbial agent being delivered to the mouth.
The thin non-porous (more preferably hydrophobic) coating ~e~e.-ts the anti-microbial agent from leA~h; ng from the particle when the particle is stored or incorporated into aqueous systems. Preferred coating materials include poly(methyl methacrylate), polystyrene, beeswax, carnauba wax, petroleum wax, polyhydroxylAl~Anoic acid, glycolipids, glycerides, phospholipids, and glycerol distearate. The coating materials may be materials (like polystyrene, waxes, or poly(methyl methacrylate) that do not degrade when exposed to enzymes in the mouth, or may be materials (like glycerol distearate, polyhydroxyAlkAnoic acid, and other glycerides) that degrade when exposed to enzymes in the mouth. All of these materials are commercially a~ailable. Preferably the coating constitutes no more than about 10% of the particle diameter.
The anti-microbial agent may be dispersed throughout the particle along with the degradable material, enclosed within a skin composed of the degradable material, or attAc to a skin composed of the degradable material.
-W096/11666 PCT~S95/13337 In the latter ~hodiment, the degradable material and the anti-microbial agent may ha~e opposite ionic charges and the anti-microbial agent may be adsorbed onto the skin by ionic h~n~; ng .
The preferred particles are microspheres that have an average diameter between 0.05 ~m and 100 ~m, more preferably between 0.1 ~m and 30 ~m. If the particles are too large they will too easily wash away from oral surfaces and thus will be less likely to settle subgingi~ally.
The preferred particles can be made by numerous con~entional, well-known methods.
These include solvent e~aporation methods, with or without a surface acti~e agent as necessary, coacervation in all its ~arious forms, pan coating, air-suspension coating, press coating, spray-drying, rotational s-uspension-separation techniques, melt coating methods, interfacial polymerization, melt-granulation processes and any and all related methods that yield the desired particles as described. Such methods may or may not use organic solvents. Such methods may encapsulate from solution, from the melt or in powdered (solid state) form. Once formed, the particles may be chemically modified (e.g., charged or made magnetic). The particles are then coated with a water stable material.
See, for example, the particle-making and particle-coating procedures described generally in Parrott, Pharmaceutical Technoloqy, pp. 86-91 (Burgess Pub. Co. 1970); Deasy, Microenca~sulation and Related Druq Procedures, pp. 1-60 (Marcel Dekker, Inc. 1984); Muller et al., J. Controlled Release, 20 (1992):237-246;
Pekarek et al., Nature, v. 367 (1994):258-60;
W096/11666 PCT~S95/13337 Muller et al., Pharm. Pharmacol. Lett. ~. 3 (1993):67-70; and Juliano (ed.), Druq DeliverY
Systems (Oxford Uni~ersity Press 1980).
The preferred particles can be placed in the mouth of a patient, e.g., by a dental instrument, or can be delivered to the mouth during routine dental hygiene, e.g., using a toothbrush, dental floss, oral rinse or toothpaste. Once the particles are in the oral ca~ity, they will settle out around the gll~li ~ettle subgingi~ally, adhere to soft tissue and become ;mmobilized in these areas. The coating can be partially remo~ed during a~inistration of the particles to the mouth, or subsequently during chewing or br~Rh; ng. If the coating is a material that degrades when contacted with enzymes in the mouth, the coating will additionally (or solely) be removed by degradation after exposure to the enzyme~.
Once the particle ha~ settled, ~arious release mechanisms are possible. The operative release me~han;sm(s) will depend upon the formulation of the particle. Thus, as the degradable material erodes, anti-microbial agent is released. This site-specific release can continue (12 hr to se~eral weeks to se~eral months) until the entire particle is degraded or w~Rh~ from the mouth or swallowed. If the latter occurs, final degradation will occur in the stomach and/or gastrointestinal tract.
Thus, no long term build-up of particles systemically should occur.
The following are examples of the procedures used to make and administer particles of the present invention.
W096111666 PCT~S95/13337 ExamDle 1: Deqradable Particles Degradable particles consisting of poly(D~-lactide)-co-glycolide, 80:20, were prepared according to the following procedure:
1. 25 mg poly(DL-lactide)-co-glycolide were dissolved in 2 ml methylene chloride.
2. A 1 wt % solution of polyvinylalcohol (87-89%
hydrolyzed) was prepared.
WO96/11666 PCT~S95/13337 Other preferred anti-micro~ial agents were described above and generally, like chlorhexidene digluconate, are commercially a~ailable.
The particles preferably include between 1% and 75%, and more preferably betwoen 1% and 25%, of the anti-microbial agent by weight. Too much anti-microbial agent may adversely affect the mechanical strength of the particle, while too little anti-microbial agent may result in an insufficient dosage of the anti-microbial agent being delivered to the mouth.
The thin non-porous (more preferably hydrophobic) coating ~e~e.-ts the anti-microbial agent from leA~h; ng from the particle when the particle is stored or incorporated into aqueous systems. Preferred coating materials include poly(methyl methacrylate), polystyrene, beeswax, carnauba wax, petroleum wax, polyhydroxylAl~Anoic acid, glycolipids, glycerides, phospholipids, and glycerol distearate. The coating materials may be materials (like polystyrene, waxes, or poly(methyl methacrylate) that do not degrade when exposed to enzymes in the mouth, or may be materials (like glycerol distearate, polyhydroxyAlkAnoic acid, and other glycerides) that degrade when exposed to enzymes in the mouth. All of these materials are commercially a~ailable. Preferably the coating constitutes no more than about 10% of the particle diameter.
The anti-microbial agent may be dispersed throughout the particle along with the degradable material, enclosed within a skin composed of the degradable material, or attAc to a skin composed of the degradable material.
-W096/11666 PCT~S95/13337 In the latter ~hodiment, the degradable material and the anti-microbial agent may ha~e opposite ionic charges and the anti-microbial agent may be adsorbed onto the skin by ionic h~n~; ng .
The preferred particles are microspheres that have an average diameter between 0.05 ~m and 100 ~m, more preferably between 0.1 ~m and 30 ~m. If the particles are too large they will too easily wash away from oral surfaces and thus will be less likely to settle subgingi~ally.
The preferred particles can be made by numerous con~entional, well-known methods.
These include solvent e~aporation methods, with or without a surface acti~e agent as necessary, coacervation in all its ~arious forms, pan coating, air-suspension coating, press coating, spray-drying, rotational s-uspension-separation techniques, melt coating methods, interfacial polymerization, melt-granulation processes and any and all related methods that yield the desired particles as described. Such methods may or may not use organic solvents. Such methods may encapsulate from solution, from the melt or in powdered (solid state) form. Once formed, the particles may be chemically modified (e.g., charged or made magnetic). The particles are then coated with a water stable material.
See, for example, the particle-making and particle-coating procedures described generally in Parrott, Pharmaceutical Technoloqy, pp. 86-91 (Burgess Pub. Co. 1970); Deasy, Microenca~sulation and Related Druq Procedures, pp. 1-60 (Marcel Dekker, Inc. 1984); Muller et al., J. Controlled Release, 20 (1992):237-246;
Pekarek et al., Nature, v. 367 (1994):258-60;
W096/11666 PCT~S95/13337 Muller et al., Pharm. Pharmacol. Lett. ~. 3 (1993):67-70; and Juliano (ed.), Druq DeliverY
Systems (Oxford Uni~ersity Press 1980).
The preferred particles can be placed in the mouth of a patient, e.g., by a dental instrument, or can be delivered to the mouth during routine dental hygiene, e.g., using a toothbrush, dental floss, oral rinse or toothpaste. Once the particles are in the oral ca~ity, they will settle out around the gll~li ~ettle subgingi~ally, adhere to soft tissue and become ;mmobilized in these areas. The coating can be partially remo~ed during a~inistration of the particles to the mouth, or subsequently during chewing or br~Rh; ng. If the coating is a material that degrades when contacted with enzymes in the mouth, the coating will additionally (or solely) be removed by degradation after exposure to the enzyme~.
Once the particle ha~ settled, ~arious release mechanisms are possible. The operative release me~han;sm(s) will depend upon the formulation of the particle. Thus, as the degradable material erodes, anti-microbial agent is released. This site-specific release can continue (12 hr to se~eral weeks to se~eral months) until the entire particle is degraded or w~Rh~ from the mouth or swallowed. If the latter occurs, final degradation will occur in the stomach and/or gastrointestinal tract.
Thus, no long term build-up of particles systemically should occur.
The following are examples of the procedures used to make and administer particles of the present invention.
W096111666 PCT~S95/13337 ExamDle 1: Deqradable Particles Degradable particles consisting of poly(D~-lactide)-co-glycolide, 80:20, were prepared according to the following procedure:
1. 25 mg poly(DL-lactide)-co-glycolide were dissolved in 2 ml methylene chloride.
2. A 1 wt % solution of polyvinylalcohol (87-89%
hydrolyzed) was prepared.
3. The methylene chloride solution was added (all at once) to 30 ml of the 1 % polyvinylalcohol solution.
4. The resulting emulsion was vortexed for 1 minute and then sonicated for 1 minute, providing a turbid emulsion.
5. The turbid emulsion was placed in a large-mouthed flask and stirred under medium speed to allow the methylene chloride to ~v~ te.
The resulting white microparticles were allowed to settle, washed with water, and freeze dried. The particles had a particle size of 30-100 ~m.
Exa le 2: Coatinq Deqradable Particles 1. The particles from Example 1 were emulsified in 30 ml of 1 wt %
polyvinylalcohol ~olution.
2. 10 mg of polystyrene were dissolved in 2 ml of methylene chloride.
3. The polystyrene solution was added (all at once) to the polyvinylalcohol solution.
W096/11666 PCT~S95/13337 4. The resulting emulsion was vortexed for 1 minute and then sonicated for 1 minute, providing a turbid emulsion.
5. The turbid emulsion was placed in a large-mouthed flask and stirred under medium speed to ev~Gl~te the methylene chloride. The resulting microparticles were centrifuged, washed, and freeze-dried.
The resulting white microparticles were allowed to settle, washed with water, and freeze dried. The particles had a particle size of 30-100 ~m.
Exa le 2: Coatinq Deqradable Particles 1. The particles from Example 1 were emulsified in 30 ml of 1 wt %
polyvinylalcohol ~olution.
2. 10 mg of polystyrene were dissolved in 2 ml of methylene chloride.
3. The polystyrene solution was added (all at once) to the polyvinylalcohol solution.
W096/11666 PCT~S95/13337 4. The resulting emulsion was vortexed for 1 minute and then sonicated for 1 minute, providing a turbid emulsion.
5. The turbid emulsion was placed in a large-mouthed flask and stirred under medium speed to ev~Gl~te the methylene chloride. The resulting microparticles were centrifuged, washed, and freeze-dried.
6. The coated particles were viewed using a high-power microscope.
The core of degradable material and the polystyrene coating were clearly visible.
Exam~le 3: Degradable Particles Including Chlorhexidene Gluconate 1. 10 mg of chlorhexidene gluconate were a~e~ to 5 ml of methylene chloride. The mixture was sonicated to reduce the particle size of the chlorhexidene gluconate. 50 mg of the degradable polymer described in Exam~le 1 were added, and the resulting mixture was vortexed to dissolve the polymer.
2. The methylene chloride solution was added (all at once) to the polyvinylalcohol solution.
3. The resulting emulsion was vortexed for 1 minute and then sonicated for 1 minute, providing a turbid emulsion.
4. The turbid emulsion was placed in a large-mouthed flask and stirred W096/11666 PCT~S95/13337 under medium speed to evaporate the methylene chloride. The resulting microparticles were centrifuged, washed, and freeze-dried. The particles then can be coated by the same procedure described in Example 2.
ExamDle 4: Degradable Particles Including Chlorhexidene (Free-Base) 1. 10 mg of chlorhexidene (free-base) were emulsified in 5 ml of methylene chloride. The emulsion was sonicated to reduce particle size of the chlorhexidene.
2. 50 mg of the degradable polymer described in Example 1 were a~e~.
The mixture was vortexed to dissolve the polymer.
3. The reRulting emulsion was poured into 40 ml of 1% polyvinylalcohol solution, and the resulting mixture ~ortexed and sonicated, providing a turbid emulsion.
4. The turbid emulsion was placed in a large-mouthed flask and stirred under medium speed to evaporate the methylene chloride. The resulting microparticles were centrifuged, washed, and freeze-dried. The particles then can be coated by the same procedure described in Example 2.
Exa le 5: Degradable Particles Including Chlorhexidene (Free-Base) 1. 10 mg of chlorhexidene (free-base) were dissolved in 5 ml of ethyl acetate.
2. 50 mg of the degradable polymer Wo 96/11666 PCT/US95/13337 described in Example i were added.
The resulting mixture was vortexed to dissolve the polymer.
3 . The resulting Eol~lt; ~n was poured into 40 ml of 1% polyvinyl~l~^h~l solution, and the mixture vortexed and sonicated, providing ~ turbid 1 ~ i r~n .
4. The turbid ~ n was placed in a large-mouthed flask and stirred under medium speed to evaporate the ethyl acetate. The resulting microparticles were centrifuged, washed, and freeze-dried. The particles then can be coated ~y the sam~ C~ e described in Example 2 .
Other . ' -''- tB are within the claims. For example, the entire de5~ le 20 particle can be - _-FE~ of the anti-microbial agent and a material like glycerol distearate that is water stable but degrades when exposed to mouth enzymes.
The core of degradable material and the polystyrene coating were clearly visible.
Exam~le 3: Degradable Particles Including Chlorhexidene Gluconate 1. 10 mg of chlorhexidene gluconate were a~e~ to 5 ml of methylene chloride. The mixture was sonicated to reduce the particle size of the chlorhexidene gluconate. 50 mg of the degradable polymer described in Exam~le 1 were added, and the resulting mixture was vortexed to dissolve the polymer.
2. The methylene chloride solution was added (all at once) to the polyvinylalcohol solution.
3. The resulting emulsion was vortexed for 1 minute and then sonicated for 1 minute, providing a turbid emulsion.
4. The turbid emulsion was placed in a large-mouthed flask and stirred W096/11666 PCT~S95/13337 under medium speed to evaporate the methylene chloride. The resulting microparticles were centrifuged, washed, and freeze-dried. The particles then can be coated by the same procedure described in Example 2.
ExamDle 4: Degradable Particles Including Chlorhexidene (Free-Base) 1. 10 mg of chlorhexidene (free-base) were emulsified in 5 ml of methylene chloride. The emulsion was sonicated to reduce particle size of the chlorhexidene.
2. 50 mg of the degradable polymer described in Example 1 were a~e~.
The mixture was vortexed to dissolve the polymer.
3. The reRulting emulsion was poured into 40 ml of 1% polyvinylalcohol solution, and the resulting mixture ~ortexed and sonicated, providing a turbid emulsion.
4. The turbid emulsion was placed in a large-mouthed flask and stirred under medium speed to evaporate the methylene chloride. The resulting microparticles were centrifuged, washed, and freeze-dried. The particles then can be coated by the same procedure described in Example 2.
Exa le 5: Degradable Particles Including Chlorhexidene (Free-Base) 1. 10 mg of chlorhexidene (free-base) were dissolved in 5 ml of ethyl acetate.
2. 50 mg of the degradable polymer Wo 96/11666 PCT/US95/13337 described in Example i were added.
The resulting mixture was vortexed to dissolve the polymer.
3 . The resulting Eol~lt; ~n was poured into 40 ml of 1% polyvinyl~l~^h~l solution, and the mixture vortexed and sonicated, providing ~ turbid 1 ~ i r~n .
4. The turbid ~ n was placed in a large-mouthed flask and stirred under medium speed to evaporate the ethyl acetate. The resulting microparticles were centrifuged, washed, and freeze-dried. The particles then can be coated ~y the sam~ C~ e described in Example 2 .
Other . ' -''- tB are within the claims. For example, the entire de5~ le 20 particle can be - _-FE~ of the anti-microbial agent and a material like glycerol distearate that is water stable but degrades when exposed to mouth enzymes.
Claims (19)
1. A method for inhibiting bacteria in the mouth of a patient, comprising:
placing a particle comprising a degradable material and an anti-microbial agent in the mouth of a patient, said particle having a water-stable exterior, said degradable material, after said particle is placed in said mouth, degrading to cause release of said anti-microbial agent, thereby inhibiting bacteria in said mouth of said patient.
placing a particle comprising a degradable material and an anti-microbial agent in the mouth of a patient, said particle having a water-stable exterior, said degradable material, after said particle is placed in said mouth, degrading to cause release of said anti-microbial agent, thereby inhibiting bacteria in said mouth of said patient.
2. The method of claim 1, wherein said anti-microbial agent is chlorhexidene or an acceptable salt thereof.
3. The method of claim 1, wherein said degradable material is a degradable polymer.
4. The method of claim 1, wherein said degradable polymer is selected from the group consisting of polyglycolic acid, polylactic acid, copolymers of glycolic acid and lactic acid, and glycerol distearate.
S. The method of claim 1, wherein said water-stable exterior is in the form of a non-porous coating comprising a water stable material which does not significantly degrade when contacted with enzymes found in the mouth.
6. The method of claim 5, wherein said water-stable material is selected from the group consisting of poly(methyl methacrylate), polystyrene, and waxes.
7. The method of claim 1, wherein said water-stable exterior is in the form of a non-porous coating which degrades when contacted with enzymes found in the mouth.
8. The method of claim 7, wherein said water-stable material comprises glycerol distearate.
9. The method of claim 1, wherein said degradable material is a material which is water stable.
10. The method of claim 9, wherein said degradable material comprises glycerol distearate.
11. The method of claim 1, wherein said anti-microbial agent and said degradable material are dispersed throughout said particle.
12. The method of claim 1, wherein said particle is a microsphere.
13. The method of claim 1, wherein said particle has an average diameter between 0.05 µm and 100 µm, inclusive.
14. The method of claim 13, wherein said particle has an average diameter between 0.1 µm and 30 µm, inclusive.
15. The method of claim 1, wherein said particle comprises between 1 percent and 75 percent of said anti-microbial agent by weight.
16. A toothbrush comprising a handle and a head with bristles, wherein said bristles comprise particles comprising a degradable material and an anti-microbial agent, said particle having a water-stable exterior.
17. Dental floss comprising an elongated length of flexible cord comprising particles comprising a degradable material and an anti-microbial agent, said particle having a water-stable exterior.
18. Toothpaste comprising particles comprising a degradable material and an anti-microbial agent, said particle having a water-stable exterior.
19. An oral rinse suitable for use in oral care, comprising water and particles comprising a degradable material and an anti-microbial agent, said particles having a water-stable exterior.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/322,926 US5616315A (en) | 1994-10-13 | 1994-10-13 | Particles including degradable material and anti-microbial agent |
US322,926 | 1994-10-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2202497A1 true CA2202497A1 (en) | 1996-04-25 |
Family
ID=23257059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002202497A Abandoned CA2202497A1 (en) | 1994-10-13 | 1995-10-11 | Particles including degradable material and anti-microbial agent |
Country Status (6)
Country | Link |
---|---|
US (2) | US5616315A (en) |
EP (1) | EP0785766A1 (en) |
AU (1) | AU712567B2 (en) |
BR (1) | BR9509344A (en) |
CA (1) | CA2202497A1 (en) |
WO (1) | WO1996011666A1 (en) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6020312A (en) * | 1994-09-13 | 2000-02-01 | Nce Pharmaceuticals, Inc. | Synthetic antibiotics |
US5616315A (en) * | 1994-10-13 | 1997-04-01 | Gillette Canada Inc. | Particles including degradable material and anti-microbial agent |
WO1997006696A1 (en) * | 1995-08-15 | 1997-02-27 | Robert Eric Montgomery | Improved proteinaceous animal chew with dentally therapeutic cation |
US5836769A (en) | 1996-12-03 | 1998-11-17 | Gillette Canada Inc. | Toothbrush, method of making a toothbrush, and method of brushing teeth |
US6026829A (en) * | 1997-06-17 | 2000-02-22 | Gillette Canada Inc. | Dental floss containing encapsulating flavoring material |
RU2202220C2 (en) * | 1997-12-30 | 2003-04-20 | Вм. Ригли Дж. Компани | Method of producing ready-made chewing gum containing antibacterial agent with controlled release (versions) and ready-made chewing gum |
US6592912B1 (en) * | 1997-12-30 | 2003-07-15 | Wm. Wrigley Jr. Company | Method of controlling release of antimicrobial agents from chewing gum and gum produced thereby |
US7354596B1 (en) * | 1998-05-01 | 2008-04-08 | 3M Innovative Properties Company | Anti-microbial agent delivery system |
US6689372B1 (en) * | 1998-08-04 | 2004-02-10 | Ciba Specialty Chemicals Corporation | Microbicidal active substances |
DE19919770A1 (en) * | 1999-04-30 | 2000-11-02 | Henkel Kgaa | Use of nanoscale antimicrobial agents in oral and / or dental care |
JP2003527168A (en) | 1999-12-28 | 2003-09-16 | キンバリー クラーク ワールドワイド インコーポレイテッド | Controlled release antimicrobial wipes for hard surfaces |
AU774993B2 (en) | 1999-12-28 | 2004-07-15 | Kimberly-Clark Worldwide, Inc. | Use-dependent indicator system for absorbent articles |
US7785572B2 (en) | 2000-03-17 | 2010-08-31 | Lg Household And Health Care Ltd. | Method and device for teeth whitening using a dry type adhesive |
BRPI0109371B1 (en) | 2000-03-17 | 2016-02-16 | Lg Household & Health Care Ltd | dry type dental bleaching plasters |
US8652446B2 (en) | 2000-03-17 | 2014-02-18 | Lg Household & Healthcare Ltd. | Apparatus and method for whitening teeth |
US6689344B2 (en) | 2000-03-17 | 2004-02-10 | Lg Household & Healthcare Ltd. | Patches for teeth whitening |
US6565873B1 (en) * | 2000-10-25 | 2003-05-20 | Salvona Llc | Biodegradable bioadhesive controlled release system of nano-particles for oral care products |
US6589562B1 (en) * | 2000-10-25 | 2003-07-08 | Salvona L.L.C. | Multicomponent biodegradable bioadhesive controlled release system for oral care products |
US6887493B2 (en) * | 2000-10-25 | 2005-05-03 | Adi Shefer | Multi component controlled release system for oral care, food products, nutraceutical, and beverages |
US7017591B2 (en) * | 2001-08-23 | 2006-03-28 | International Tape Partners Llc | Particulate coated monofilament devices |
US7067152B2 (en) * | 2002-04-17 | 2006-06-27 | Salvona Llc | Multi component moisture triggered controlled release system that imparts long lasting cooling sensation on the target site and/or provides high impact fragrance or flavor burst |
US6984128B2 (en) * | 2002-11-01 | 2006-01-10 | Bas Medical, Inc. | Methods for enabling and stabilizing tooth movement |
US20050186526A1 (en) * | 2002-11-01 | 2005-08-25 | Bas Medical, Inc. | Methods and systems for enabling and stabilizing tooth movement |
US7666410B2 (en) * | 2002-12-20 | 2010-02-23 | Kimberly-Clark Worldwide, Inc. | Delivery system for functional compounds |
US8409618B2 (en) * | 2002-12-20 | 2013-04-02 | Kimberly-Clark Worldwide, Inc. | Odor-reducing quinone compounds |
US7152611B2 (en) * | 2002-12-30 | 2006-12-26 | International Tape Partners, Llc | Coated multifilament dental devices overcoated with imbedded particulate |
US6669929B1 (en) * | 2002-12-30 | 2003-12-30 | Colgate Palmolive Company | Dentifrice containing functional film flakes |
US7794737B2 (en) * | 2003-10-16 | 2010-09-14 | Kimberly-Clark Worldwide, Inc. | Odor absorbing extrudates |
US7678367B2 (en) * | 2003-10-16 | 2010-03-16 | Kimberly-Clark Worldwide, Inc. | Method for reducing odor using metal-modified particles |
US7879350B2 (en) * | 2003-10-16 | 2011-02-01 | Kimberly-Clark Worldwide, Inc. | Method for reducing odor using colloidal nanoparticles |
US7438875B2 (en) * | 2003-10-16 | 2008-10-21 | Kimberly-Clark Worldwide, Inc. | Method for reducing odor using metal-modified silica particles |
US20050163825A1 (en) * | 2004-01-27 | 2005-07-28 | Naidu A. S. | Lactoferrin-treated filament materials |
US20060243298A1 (en) * | 2005-04-28 | 2006-11-02 | The Procter & Gamble Company | Dental floss compositions comprising menthol and carboxamides |
US7595280B2 (en) * | 2005-08-16 | 2009-09-29 | Halliburton Energy Services, Inc. | Delayed tackifying compositions and associated methods involving controlling particulate migration |
US20070148213A1 (en) * | 2005-12-22 | 2007-06-28 | Sayed Ibrahim | Film containing compositions |
CN101505769A (en) * | 2006-06-30 | 2009-08-12 | 皮瑞缪生命科学有限公司 | Herbal compositions for the treatment of diseases of the oral cavity |
US8178483B2 (en) * | 2007-03-30 | 2012-05-15 | Colgate-Palmolive Company | Polymeric encapsulates having a quaternary ammonium salt and methods for producing the same |
US20090163887A1 (en) * | 2007-12-20 | 2009-06-25 | Arehart Kelly D | Odor control cellulose granules with quinone compounds |
US20090188521A1 (en) * | 2008-01-17 | 2009-07-30 | Evazynajad Ali M | Dental Floss Formed from Botanic and Botanically Derived Fiber |
US8282298B2 (en) * | 2008-06-26 | 2012-10-09 | Colgate-Palmolive Company | Oral care implement |
TWI462709B (en) | 2010-03-31 | 2014-12-01 | Colgate Palmolive Co | Oral care implement with rapid flavor release |
US20140026916A1 (en) * | 2012-07-25 | 2014-01-30 | College Of William And Mary | Method for Reducing Marine Pollution Using Polyhydroxyalkanoate Microbeads |
DE102013209892A1 (en) * | 2013-05-28 | 2014-12-04 | Henkel Ag & Co. Kgaa | Oral and dental care and cleanser with increased antibacterial effect |
DE102013209893A1 (en) * | 2013-05-28 | 2014-12-04 | Henkel Ag & Co. Kgaa | Taste-optimized oral and dental care and cleaning agents |
JP2017505824A (en) | 2014-02-17 | 2017-02-23 | ザ プロクター アンド ギャンブル カンパニー | Skin cleansing composition comprising biodegradable abrasive particles |
WO2019245630A1 (en) | 2018-06-21 | 2019-12-26 | Healthy Advances, Inc. | Encapsulated antimicrobials and related methods of treatment |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US24899A (en) * | 1859-07-26 | Edwabd f | ||
NL95043C (en) * | 1953-06-30 | |||
BE634668A (en) * | 1962-07-11 | |||
US3934001A (en) * | 1965-12-07 | 1976-01-20 | Lever Brothers Company | Oral compositions containing germicidally active plastic powders |
US3959457A (en) * | 1970-06-05 | 1976-05-25 | Temple University | Microparticulate material and method of making such material |
US3699979A (en) * | 1971-04-08 | 1972-10-24 | Indiana University Foundation | Impregnated article for cleaning the interproximal surfaces of the teeth |
US3991766A (en) * | 1973-05-31 | 1976-11-16 | American Cyanamid Company | Controlled release of medicaments using polymers from glycolic acid |
US3957964A (en) * | 1974-01-30 | 1976-05-18 | Colgate-Palmolive Company | Dentifrice containing encapsulated flavoring |
US3943949A (en) * | 1974-11-26 | 1976-03-16 | Johnson & Johnson | Flavored dental articles |
US4071614A (en) * | 1975-06-03 | 1978-01-31 | Colgate Palmolive Company | Dentifrice containing encapsulated flavoring |
US4033365A (en) * | 1976-01-23 | 1977-07-05 | Johnson & Johnson | Flavored dental articles |
US4348378A (en) * | 1979-08-09 | 1982-09-07 | Kosti Carl M | Plaque disclosing dentifrice compositions with semi-solid microcapsules of dye |
US4622244A (en) * | 1979-09-04 | 1986-11-11 | The Washington University | Process for preparation of microcapsules |
US4389330A (en) * | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process |
US4685883A (en) * | 1983-09-12 | 1987-08-11 | Jernberg Gary R | Local delivery of chemotherapeutic agents for the treatment of periodontal disease |
US4892736A (en) * | 1983-10-07 | 1990-01-09 | The Forsyth Dental Infirmary For Children | Intra-pocket drug delivery devices for treatment of periodontal diseases |
US4568559A (en) * | 1984-02-06 | 1986-02-04 | Biotek, Inc. | Composite core coated microparticles and process of preparing same |
US4623588A (en) * | 1984-02-06 | 1986-11-18 | Biotek, Inc. | Controlled release composite core coated microparticles |
US4837007A (en) * | 1985-12-11 | 1989-06-06 | Lever Brothers Company | Fluoridating oral cavity |
GB8601100D0 (en) * | 1986-01-17 | 1986-02-19 | Cosmas Damian Ltd | Drug delivery system |
US4919939A (en) * | 1986-04-29 | 1990-04-24 | Pharmetrix Corporation | Periodontal disease treatment system |
US4780320A (en) * | 1986-04-29 | 1988-10-25 | Pharmetrix Corp. | Controlled release drug delivery system for the periodontal pocket |
US5219554A (en) * | 1986-07-03 | 1993-06-15 | Advanced Magnetics, Inc. | Hydrated biodegradable superparamagnetic metal oxides |
US4828955A (en) * | 1986-10-27 | 1989-05-09 | Japan Synthetic Rubber Co., Ltd. | Microencapsulated particles and process for production thereof |
US4867988A (en) * | 1987-04-08 | 1989-09-19 | Production Previews, Inc. | Dentifrice containing microencapsulated oxygen |
US4861627A (en) * | 1987-05-01 | 1989-08-29 | Massachusetts Institute Of Technology | Preparation of multiwall polymeric microcapsules |
JPH0725649B2 (en) * | 1987-10-12 | 1995-03-22 | 而至歯科工業株式会社 | Disinfectant-containing alginate impression material |
US4978391A (en) * | 1987-11-13 | 1990-12-18 | Dentsply Management Corp. | Intraoral medicament delivery and procedure |
US5061106A (en) * | 1988-03-08 | 1991-10-29 | Colgate-Palmolive Company | Toothbrush with slow release of disinfectant and antibacterial agents and method of manufacturing the same |
US4917892A (en) * | 1988-06-28 | 1990-04-17 | Temple University | Encapsulated topical delivery system |
US5098711A (en) * | 1988-11-14 | 1992-03-24 | Ira Hill | Method of treating the oral cavity with dental floss containing chemotherapeutic agents |
US4980150A (en) * | 1989-04-27 | 1990-12-25 | Zetachron, Inc. | Chlorhexidine complex |
US5262166A (en) * | 1991-04-17 | 1993-11-16 | Lty Medical Inc | Resorbable bioactive phosphate containing cements |
FR2676362B3 (en) * | 1991-05-17 | 1993-08-13 | Oreal | PROCESS FOR INCREASING THE ACTIVITY OF AT LEAST ONE ACTIVE IN A COMPOSITION FOR COSMETIC AND / OR DERMOPHARMACEUTICAL USE AND COMPOSITION FOR CARRYING OUT SAID METHOD. |
DE4293451T1 (en) * | 1991-09-13 | 1994-09-08 | Gillette Canada | Polymer particles for dental applications |
US5250288A (en) * | 1991-09-13 | 1993-10-05 | Gillette Canada, Inc. | Method for desensitizing teeth |
US5211939A (en) * | 1991-09-13 | 1993-05-18 | Gillette Canada | Method for desensitizing teeth |
CA2125483A1 (en) * | 1991-12-11 | 1993-06-24 | Mary Ann Hunter | Cetylpyridinium chloride and domiphen bromide in organic solvent |
US5225282A (en) * | 1991-12-13 | 1993-07-06 | Molecular Bioquest, Inc. | Biodegradable magnetic microcluster comprising non-magnetic metal or metal oxide particles coated with a functionalized polymer |
US5281265A (en) * | 1992-02-03 | 1994-01-25 | Liu Sung Tsuen | Resorbable surgical cements |
US5614223A (en) * | 1992-05-04 | 1997-03-25 | Digestive Care Inc. | Intraoral medicament-releasing device |
US5242910A (en) * | 1992-10-13 | 1993-09-07 | The Procter & Gamble Company | Sustained release compositions for treating periodontal disease |
US5447725A (en) * | 1993-06-11 | 1995-09-05 | The Procter & Gamble Company | Methods for aiding periodontal tissue regeneration |
US5616315A (en) * | 1994-10-13 | 1997-04-01 | Gillette Canada Inc. | Particles including degradable material and anti-microbial agent |
US5779471A (en) * | 1995-03-08 | 1998-07-14 | Gillette Canada Inc. | Delivery of substance to the mouth |
-
1994
- 1994-10-13 US US08/322,926 patent/US5616315A/en not_active Expired - Lifetime
-
1995
- 1995-10-11 EP EP95936356A patent/EP0785766A1/en not_active Withdrawn
- 1995-10-11 CA CA002202497A patent/CA2202497A1/en not_active Abandoned
- 1995-10-11 BR BR9509344A patent/BR9509344A/en not_active Application Discontinuation
- 1995-10-11 AU AU38340/95A patent/AU712567B2/en not_active Ceased
- 1995-10-11 WO PCT/US1995/013337 patent/WO1996011666A1/en not_active Application Discontinuation
-
1997
- 1997-01-16 US US08/783,461 patent/US6007795A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
BR9509344A (en) | 1997-11-04 |
WO1996011666A1 (en) | 1996-04-25 |
US5616315A (en) | 1997-04-01 |
EP0785766A1 (en) | 1997-07-30 |
AU712567B2 (en) | 1999-11-11 |
US6007795A (en) | 1999-12-28 |
AU3834095A (en) | 1996-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU712567B2 (en) | Particles including degradable material and anti-microbial agent | |
CA2204517C (en) | Desensitizing teeth with degradable particles | |
US6589562B1 (en) | Multicomponent biodegradable bioadhesive controlled release system for oral care products | |
US6565873B1 (en) | Biodegradable bioadhesive controlled release system of nano-particles for oral care products | |
AU675206B2 (en) | Polymeric particles for dental applications | |
US20100015068A1 (en) | Methods and Compositions For Altering Biological Surfaces | |
MXPA05001076A (en) | Microcapsules with modified release of active principles with low solubility for oral delivery. | |
JPH0352980B2 (en) | ||
WO1999004764A1 (en) | Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity | |
JP2022106703A (en) | Personal dental care product for caries treatment | |
JP2857789B2 (en) | Toothpaste | |
WO2005072261A2 (en) | Lactoferrin-treated filament materials | |
Landa et al. | A comparison of the detachment of an adhering oral streptococcal strain stimulated by mouthrinses and a pre‐brushing rinse | |
AU704007B2 (en) | Toothbrushes | |
MXPA99011151A (en) | Dental hygiene article |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |